154 related articles for article (PubMed ID: 20373734)
1. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa.
Stickland HG; Davenport PW; Lilley KS; Griffin JL; Welch M
J Proteome Res; 2010 Jun; 9(6):2957-67. PubMed ID: 20373734
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa.
Purssell A; Poole K
Microbiology (Reading); 2013 Oct; 159(Pt 10):2058-2073. PubMed ID: 23924707
[TBL] [Abstract][Full Text] [Related]
3. EsrC, an envelope stress-regulated repressor of the mexCD-oprJ multidrug efflux operon in Pseudomonas aeruginosa.
Purssell A; Fruci M; Mikalauskas A; Gilmour C; Poole K
Environ Microbiol; 2015 Jan; 17(1):186-98. PubMed ID: 25143244
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.
Poole K; Gotoh N; Tsujimoto H; Zhao Q; Wada A; Yamasaki T; Neshat S; Yamagishi J; Li XZ; Nishino T
Mol Microbiol; 1996 Aug; 21(4):713-24. PubMed ID: 8878035
[TBL] [Abstract][Full Text] [Related]
5. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
Jeannot K; Elsen S; Köhler T; Attree I; van Delden C; Plésiat P
Antimicrob Agents Chemother; 2008 Jul; 52(7):2455-62. PubMed ID: 18474583
[TBL] [Abstract][Full Text] [Related]
6. Real-Time Monitoring of
Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
[TBL] [Abstract][Full Text] [Related]
8. Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa.
Gotoh N; Tsujimoto H; Nomura A; Okamoto K; Tsuda M; Nishino T
FEMS Microbiol Lett; 1998 Aug; 165(1):21-7. PubMed ID: 9711836
[TBL] [Abstract][Full Text] [Related]
9. nfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosa.
Monti MR; Morero NR; Miguel V; Argaraña CE
PLoS One; 2013; 8(6):e66236. PubMed ID: 23762483
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Mulet X; Maciá MD; Mena A; Juan C; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2009 Apr; 53(4):1552-60. PubMed ID: 19188376
[TBL] [Abstract][Full Text] [Related]
11. Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ.
Hosaka M; Gotoh N; Nishino T
Antimicrob Agents Chemother; 1995 Aug; 39(8):1731-5. PubMed ID: 7486910
[TBL] [Abstract][Full Text] [Related]
12. A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance.
Thai VC; Pham HV; Nguyen DNM; Lambert P; Nguyen TTH
Acta Microbiol Immunol Hung; 2017 Sep; 64(3):245-253. PubMed ID: 28560883
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of the Pseudomonas aeruginosa NfxB protein, the negative regulator of the nfxB gene.
Shiba T; Ishiguro K; Takemoto N; Koibuchi H; Sugimoto K
J Bacteriol; 1995 Oct; 177(20):5872-7. PubMed ID: 7592337
[TBL] [Abstract][Full Text] [Related]
14. Interplay between the efflux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa.
Germ M; Yoshihara E; Yoneyama H; Nakae T
Biochem Biophys Res Commun; 1999 Aug; 261(2):452-5. PubMed ID: 10425205
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.
Mulet X; Moyá B; Juan C; Macià MD; Pérez JL; Blázquez J; Oliver A
Antimicrob Agents Chemother; 2011 Oct; 55(10):4560-8. PubMed ID: 21807976
[TBL] [Abstract][Full Text] [Related]
16. Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa.
Masuda N; Gotoh N; Ohya S; Nishino T
Antimicrob Agents Chemother; 1996 Apr; 40(4):909-13. PubMed ID: 8849250
[TBL] [Abstract][Full Text] [Related]
17. Promoter regulatory mode evolution enhances the high multidrug resistance of
Wang C; Yang J; Xu Z; Lv L; Chen S; Hong M; Liu J-H
mBio; 2024 May; 15(5):e0021824. PubMed ID: 38564664
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa.
Gotoh N; Tsujimoto H; Tsuda M; Okamoto K; Nomura A; Wada T; Nakahashi M; Nishino T
Antimicrob Agents Chemother; 1998 Aug; 42(8):1938-43. PubMed ID: 9687387
[TBL] [Abstract][Full Text] [Related]
19. Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.
Gomis-Font MA; Pitart C; Del Barrio-Tofiño E; Zboromyrska Y; Cortes-Lara S; Mulet X; Marco F; Vila J; López-Causapé C; Oliver A
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0008921. PubMed ID: 34060900
[TBL] [Abstract][Full Text] [Related]
20. MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor.
Fraud S; Campigotto AJ; Chen Z; Poole K
Antimicrob Agents Chemother; 2008 Dec; 52(12):4478-82. PubMed ID: 18838593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]